HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients.

Abstract
A sample of 140 children exhibiting neurologic disturbances (93 suffering from epilepsy and 47 with delayed psychomotor development or mental retardation) was tested for the activity of some lysosomal enzymes. A partial deficiency of arylsulfatase A (ASA) in leucocytes (activities lower than 60% of the control average) was detected in 36 patients (25.7%), whereas few ASA-deficient individuals (1.4%) were found in the control sample of 71 healthy children. Therefore, the frequency of ASA deficiency is abnormally high in our sample of pediatric patients. ASA activity levels were also assayed on fibroblasts from 12 of the 36 ASA-deficient patients; the mean activity in these cells was 20% of the control average. Excretion of urinary sulfatides was not increased in the tested ASA-deficient patients (10/36). Clinical symptoms of these ASA-deficient patients bore no resemblance to classical metachromatic leucodystrophy (MLD), but resemble literature cases labeled as atypical MLD or diagnostic puzzles. This result suggests that reduced ASA activity might be associated with an increased risk of developing neurologic or neuropsychiatric disturbances in children.
AuthorsS Sangiorgi, A Ferlini, A Zanetti, M Mochi
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 40 Issue 3 Pg. 365-9 (Sep 01 1991) ISSN: 0148-7299 [Print] United States
PMID1683156 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cerebroside-Sulfatase
Topics
  • Adolescent
  • Cerebroside-Sulfatase (deficiency)
  • Child
  • Child, Preschool
  • Clinical Enzyme Tests
  • Female
  • Humans
  • Infant
  • Lysosomes (enzymology)
  • Male
  • Nervous System Diseases (diagnosis, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: